Biblio

Export 629 results:
[ Author(Desc)] Keyword Title Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
F. T. Gossink, Dols, A., Krudop, W. A., Sikkes, S. A., Kerssens, C. J., Prins, N. D., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., “Formal Psychiatric Disorders are not Overrepresented in Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1249-56, 2016.
J. Gräff, Rei, D., Guan, J. - S., Wang, W. - Y., Seo, J., Hennig, K. M., Nieland, T. J. F., Fass, D. M., Kao, P. F., Kahn, M., Su, S. C., Samiei, A., Joseph, N., Haggarty, S. J., Delalle, I., and Tsai, L. - H., “An epigenetic blockade of cognitive functions in the neurodegenerating brain.”, Nature, vol. 483, no. 7388, pp. 222-6, 2012.
N. Gramunt, Sánchez-Benavides, G., Buschke, H., Lipton, R. B., Masramon, X., Gispert, J. D., Peña-Casanova, J., Fauria, K., and Molinuevo, J. L., “Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity.”, J Alzheimers Dis, vol. 50, no. 4, pp. 999-1010, 2016.
G. Grande, Cucumo, V., Cova, I., Ghiretti, R., Maggiore, L., Lacorte, E., Galimberti, D., Scarpini, E., Clerici, F., Pomati, S., Vanacore, N., and Mariani, C., “Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation.”, J Alzheimers Dis, vol. 51, no. 1, pp. 57-67, 2016.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D., “Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.”, J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
M. W. Granger, Franko, B., Taylor, M. W., Messier, C., St George-Hyslop, P., and Bennett, S. A. L., “A TgCRND8 Mouse Model of Alzheimer's Disease Exhibits Sexual Dimorphisms in Behavioral Indices of Cognitive Reserve.”, J Alzheimers Dis, vol. 51, no. 3, pp. 757-73, 2016.
M. Grassi, Perna, G., Caldirola, D., Schruers, K., Duara, R., and Loewenstein, D. A., “A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1555-1573, 2018.
N. E. Gray, Zweig, J. A., Kawamoto, C., Quinn, J. F., and Copenhaver, P. F., “STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 51, no. 2, pp. 391-403, 2016.
M. A. Gregory, Silva, N. C. Boa Sort, Gill, D. P., McGowan, C. L., Liu-Ambrose, T., J Shoemaker, K., Hachinski, V., Holmes, J., and Petrella, R. J., “Combined Dual-Task Gait Training and Aerobic Exercise to Improve Cognition, Mobility, and Vascular Health in Community-Dwelling Older Adults at Risk for Future Cognitive Decline1.”, J Alzheimers Dis, vol. 57, no. 3, pp. 747-763, 2017.
A. Griciuc, Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. Hoon, Hyman, B. T., and Tanzi, R. E., “Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.”, Neuron, vol. 78, no. 4, pp. 631-43, 2013.
R. Guerreiro, Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J. - C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J., “TREM2 variants in Alzheimer's disease.”, N Engl J Med, vol. 368, no. 2, pp. 117-27, 2013.
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., “Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.
M. Guo, Peng, J., Huang, X., Xiao, L., Huang, F., and Zuo, Z., “Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 80, no. 1, pp. 299-310, 2021.
L. Guzmán-Martínez, Calfío, C., Farías, G. A., Vilches, C., Prieto, R., and Maccioni, R. B., “New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 82, no. s1, pp. S51-S63, 2021.
H
A. R. Haeusler, Donnelly, C. J., Periz, G., Simko, E. A. J., Shaw, P. G., Kim, M. - S., Maragakis, N. J., Troncoso, J. C., Pandey, A., Sattler, R., Rothstein, J. D., and Wang, J., “C9orf72 nucleotide repeat structures initiate molecular cascades of disease.”, Nature, vol. 507, no. 7491, pp. 195-200, 2014.
M. El Haj, Coello, Y., Kapogiannis, D., Gallouj, K., and Antoine, P., “Negative Prospective Memory in Alzheimer's Disease: "Do Not Perform That Action".”, J Alzheimers Dis, vol. 61, no. 2, pp. 663-672, 2018.
J. R. Hall, Wiechmann, A., Johnson, L. A., Edwards, M., and O'Bryant, S. E., “Characteristics of Cognitively Normal Mexican-Americans with Cognitive Complaints.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1485-1492, 2018.
I. Hallikainen, Hongisto, K., Välimäki, T., Hänninen, T., Martikainen, J., and Koivisto, A. M., “The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1367-1376, 2018.
H. Hampel, Toschi, N., Babiloni, C., Baldacci, F., Black, K. L., Bokde, A. L. W., Bun, R. S., Cacciola, F., Cavedo, E., Chiesa, P. A., Colliot, O., Coman, C. - M., Dubois, B., Duggento, A., Durrleman, S., Ferretti, M. - T., George, N., Genthon, R., Habert, M. - O., Herholz, K., Koronyo, Y., Koronyo-Hamaoui, M., Lamari, F., Langevin, T., Lehéricy, S., Lorenceau, J., Neri, C., Nisticò, R., Nyasse-Messene, F., Ritchie, C., Rossi, S., Santarnecchi, E., Sporns, O., Verdooner, S. R., Vergallo, A., Villain, N., Younesi, E., Garaci, F., and Lista, S., “Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.”, J Alzheimers Dis, vol. 64, no. s1, pp. S47-S105, 2018.
D. S Han, Boyle, P. A., James, B. D., Yu, L., and Bennett, D. A., “Mild Cognitive Impairment and Susceptibility to Scams in Old Age.”, J Alzheimers Dis, vol. 49, no. 3, pp. 845-51, 2016.
F. T. Hane, Robinson, M., Lee, B. Y., Bai, O., Leonenko, Z., and Albert, M. S., “Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.”, J Alzheimers Dis, vol. 57, no. 3, pp. 645-665, 2017.
C. J. D. Hardy, Buckley, A. H., Downey, L. E., Lehmann, M., Zimmerer, V. C., Varley, R. A., Crutch, S. J., Rohrer, J. D., Warrington, E. K., and Warren, J. D., “The Language Profile of Behavioral Variant Frontotemporal Dementia.”, J Alzheimers Dis, vol. 50, no. 2, pp. 359-71, 2016.
R. Harris, Miners, J. Scott, Allen, S., and Love, S., “VEGFR1 and VEGFR2 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 2, pp. 741-752, 2018.
J. Hartmann, Roßmeier, C., Riedl, L., Dorn, B., Fischer, J., Slawik, T., Fleischhaker, M., Hartmann, F., Egert-Schwender, S., Kehl, V., Haller, B., Schneider-Schelte, H., Dinkel, A., Jox, R. J., and Diehl-Schmid, J., “Quality of Life in Advanced Dementia with Late Onset, Young Onset, and Very Young Onset.”, J Alzheimers Dis, vol. 80, no. 1, pp. 283-297, 2021.
A. Hatami, Monjazeb, S., and Glabe, C., “The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils.”, J Alzheimers Dis, vol. 50, no. 2, pp. 517-25, 2016.

Pages